205 related articles for article (PubMed ID: 36445235)
1. The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading.
Christofer Juhlin C; Mete O; Baloch ZW
Endocr Relat Cancer; 2023 Feb; 30(2):. PubMed ID: 36445235
[TBL] [Abstract][Full Text] [Related]
2. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
3. WHO 2022 updates on follicular cell and c-cell derived thyroid neoplasm.
Goswami P; Patel T; Dave R; Singh G; Singh A; Kalonia T
J Med Life; 2024 Jan; 17(1):15-23. PubMed ID: 38737660
[TBL] [Abstract][Full Text] [Related]
4. Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach.
Jung CK; Bychkov A; Kakudo K
Endocrinol Metab (Seoul); 2022 Oct; 37(5):703-718. PubMed ID: 36193717
[TBL] [Abstract][Full Text] [Related]
5. Changes in the diagnosis of thyroid tumours in the 5th edition of the WHO classification of endocrine neoplasms.
J D
Cesk Patol; 2024; 60(1):59-63. PubMed ID: 38697828
[TBL] [Abstract][Full Text] [Related]
6. Classification of thyroid follicular cell tumors: with special reference to borderline lesions.
Kakudo K; Bai Y; Liu Z; Li Y; Ito Y; Ozaki T
Endocr J; 2012; 59(1):1-12. PubMed ID: 21908930
[TBL] [Abstract][Full Text] [Related]
7. The 5
Basolo F; Macerola E; Poma AM; Torregrossa L
Endocrine; 2023 Jun; 80(3):470-476. PubMed ID: 36964880
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend Regarding the Latest WHO Classification.
Chiba T
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672067
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Differentiated High-Grade Thyroid Carcinoma Among Well-Differentiated Tumors: A Systematic Review and Meta-Analysis.
Poma AM; Macerola E; Ghossein RA; Tallini G; Basolo F
Thyroid; 2024 Mar; 34(3):314-323. PubMed ID: 38115626
[No Abstract] [Full Text] [Related]
10. Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors).
Echegoyen-Silanes A; Pineda-Arribas JJ; Sánchez-Ares M; Cameselle-García S; Sobrino B; Ruíz-Ponte C; Piso-Neira M; Anda E; Cameselle-Teijeiro JM
Virchows Arch; 2023 Mar; 482(3):615-623. PubMed ID: 36689061
[TBL] [Abstract][Full Text] [Related]
11. Post-radiotherapy cribriform-morular thyroid carcinoma.
Or Koca A; Güler Şimşek G
J Clin Lab Anal; 2023 Jan; 37(1):e24819. PubMed ID: 36535913
[TBL] [Abstract][Full Text] [Related]
12. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
[TBL] [Abstract][Full Text] [Related]
13. Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway.
Cameselle-Teijeiro JM; Peteiro-González D; Caneiro-Gómez J; Sánchez-Ares M; Abdulkader I; Eloy C; Melo M; Amendoeira I; Soares P; Sobrinho-Simões M
Mod Pathol; 2018 Aug; 31(8):1168-1179. PubMed ID: 29785019
[TBL] [Abstract][Full Text] [Related]
14. Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
Nakazawa T; Celestino R; Machado JC; Cameselle-Teijeiro JM; Vinagre J; Eloy C; Benserai F; Lameche S; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2013 Aug; 21(4):379-89. PubMed ID: 23349472
[TBL] [Abstract][Full Text] [Related]
15. The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas.
Wong KS; Strickland KC; Angell TE; Nehs MA; Alexander EK; Cibas ES; Krane JF; Howitt BE; Barletta JA
Endocr Pathol; 2017 Jun; 28(2):171-176. PubMed ID: 28271380
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound and cytological characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features compared to papillary carcinomas.
Boursier L; Clerc Urmes I; Garon J; Klein M; Demarquet L
Ann Endocrinol (Paris); 2020 Feb; 81(1):28-33. PubMed ID: 32081363
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound findings of noninvasive follicular thyroid neoplasm with papillary-like nuclear features compared with those of follicular variant of papillary carcinoma and encapsulated papillary carcinoma: a single-institution study in Japan.
Oshita M; Ito Y; Miyamoto T; Ota H; Nakamura T; Hirokawa M; Miya A; Miyauchi A
Endocr J; 2020 Nov; 67(11):1147-1155. PubMed ID: 32669481
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
[TBL] [Abstract][Full Text] [Related]
19. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
Mete O; Erickson LA; Juhlin CC; de Krijger RR; Sasano H; Volante M; Papotti MG
Endocr Pathol; 2022 Mar; 33(1):155-196. PubMed ID: 35288842
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) from classic and invasive follicular-variant papillary thyroid carcinomas based on cytologic features.
Legesse T; Parker L; Heath J; Staats PN
J Am Soc Cytopathol; 2019; 8(1):11-17. PubMed ID: 30929754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]